title: Can BAFF promoter polymorphism be a predisposing condition for HCV-related mixed cryoglobulinemia?
authors.forename: Carlo
authors.initials: C
authors.lastname: Giannini
authors.forename: Laura
authors.initials: L
authors.lastname: Gragnani
authors.forename: Alessia
authors.initials: A
authors.lastname: Piluso
authors.forename: Patrizio
authors.initials: P
authors.lastname: Caini
authors.forename: Antonio
authors.initials: A
authors.lastname: Petrarca
authors.forename: Monica
authors.initials: M
authors.lastname: Monti
authors.forename: Giacomo
authors.initials: G
authors.lastname: Laffi
authors.forename: Anna Linda
authors.initials: AL
authors.lastname: Zignego
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D053264:B-Cell Activating Factor / Q000235:genetics* / Q000378:metabolism; D001402:B-Lymphocytes / Q000378:metabolism; D003449:Cryoglobulinemia / Q000209:etiology / Q000235:genetics* / Q000378:metabolism; D005260:Female; D020022:Genetic Predisposition to Disease; D006526:Hepatitis C / Q000150:complications / Q000235:genetics* / Q000378:metabolism; D006801:Humans; D008213:Lymphocyte Activation / Q000235:genetics; D008297:Male; D008875:Middle Aged; D020641:Polymorphism, Single Nucleotide; D011401:Promoter Regions, Genetic / Q000235:genetics*
chemical_list: D053264:B-Cell Activating Factor; C505719:TNFSF13B protein, human